BioSpace News Archive

Boditech Med Inc. and SphingoTec GmbH announced they have entered into a market development agreement, building on their previous licensing collaboration for the kidney function biomarker penKid.

Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization, reported results for the fiscal 2023 fourth quarter and full year ended May 28, 2023.

Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today reported financial results for the six months ended June 30, 2023 and provided corporate updates.

CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC) today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 a.m. – 12 p.m. ET/ 7:30 a.m. – 9 a.m. PT.

Avadel Pharmaceuticals plc announced that members of management will participate in the following upcoming investor conferences:

Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that that Ted White, Verrica President and CEO, will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 5:00 pm ET.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in the following investor conferences.

Integer Holdings Corporation announced that Joe Dziedzic, President and Chief Executive Officer, Diron Smith, Vice President and Interim Chief Financial Officer, and Andrew Senn, Senior Vice President, Strategy, Business Development & Investor Relations, are scheduled to participate at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023 at 1:30 p.m. ET.

Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that members of its management team will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, including a fireside chat on Tuesday, September 12, 2023 at 4:15 p.m. ET.

Prime Medicine, Inc. announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present at two upcoming investor conferences.